Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
37.44
+1.51 (4.20%)
Mar 9, 2026, 2:49 PM EDT - Market open
Sionna Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 28.72 | 13.27 | 9.71 | 6.77 |
| Research & Development | 60.26 | 57.29 | 40.63 | 34.61 |
| Operating Expenses | 88.98 | 70.56 | 50.33 | 41.37 |
| Operating Income | -88.98 | -70.56 | -50.33 | -41.37 |
| Interest & Investment Income | 13.3 | 8.17 | 2.77 | 1.13 |
| Other Non Operating Income (Expenses) | 0.42 | 0.7 | 0.3 | - |
| Pretax Income | -75.27 | -61.69 | -47.26 | -40.24 |
| Net Income | -75.27 | -61.69 | -47.26 | -40.24 |
| Net Income to Common | -75.27 | -61.69 | -47.26 | -40.24 |
| Shares Outstanding (Basic) | 40 | 4 | 3 | 3 |
| Shares Outstanding (Diluted) | 40 | 4 | 3 | 3 |
| Shares Change (YoY) | 935.60% | 31.56% | 13.80% | - |
| EPS (Basic) | -1.88 | -15.99 | -16.11 | -15.61 |
| EPS (Diluted) | -1.88 | -15.99 | -16.11 | -15.61 |
| Free Cash Flow | -66.67 | -52.81 | -44.82 | -37.94 |
| Free Cash Flow Per Share | -1.67 | -13.69 | -15.28 | -14.72 |
| EBITDA | -88.34 | -69.89 | -49.75 | -41.25 |
| D&A For EBITDA | 0.65 | 0.67 | 0.58 | 0.12 |
| EBIT | -88.98 | -70.56 | -50.33 | -41.37 |
Source: S&P Capital IQ. Standard template.
Financial Sources.